| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-661 | |
| Phytochemical name or plant extracts | Artemisia indica extract | |
| PMID | 25887417 | |
| Literature evidence | The in vitro cytotoxic activity of ethno-pharmacological important plants of Darjeeling district of West Bengal against different human cancer cell lines. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Ethanolic extract | |
| Source of phytochemicals or plant Extracts | Artemisia indica | |
| Geographical availability | Assam, Cambodia, China North-Central, China South-Central, China Southeast, East Himalaya, Hainan, India, Inner Mongolia, Japan, Korea, Laos, Manchuria, Myanmar, Nansei-shoto, Nepal, Pakistan, Philippines, Sri Lanka, Taiwan, Thailand, Tibet, Vietnam, West Himalaya | |
| Plant parts | Leaves and stem | |
| Other cancers | Breast cancer, Liver cancer, Cervical cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 48 ± 1.2 μg/ml against MCF-7 | |
| Potency | NA | |
| Cell line/ mice model | MCF-7, HepG2, HeLa | |
| Additional information | Of the five potential plant extracts, three, Artemisia indica (P4), Maesa macrophylla (P19) and Phlogacanthus thyrsiformis (P22) could inhibit the growth of HeLa and MCF7 cells. | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:179626-1 | |
| Safety | NA |